Teresa Macarulla, MD, PhD

LBA-001: Olaparib as maintenance treatment following first-line platinum-based chemotherapy in patients with a germline BRCA mutation and metastatic pancreatic cancer: Phase III POLO trial

Access the abstract 

Giampaolo Tortora ;

Talia Golan , MD;

Michael J. Hall ;

Pascal Hammel ;

Eric Van Cutsem , MD, PhD;

Teresa Macarulla , MD, PhD;

Daniel Hochhauser ;

Dirk Arnold , MD, PhD;

Anke Reinacher-Schick ;

Eileen M. O'Reilly ;

David McGuinness ;

Katia Schlienger ;

Gershon Y. Locker ;

Hedy L. Kindler ;

07/31/2019

O-002: Ibrutinib in Combination With Nab-Paclitaxel and Gemcitabine as First-Line Treatment for Patients With Metastatic Pancreatic Adenocarcinoma: Results From the Phase 3 RESOLVE Study

Access the abstract

Jean-Baptiste Bachet ;

Heung-Moon Chang ;

Lisa M. Coussens ;

Lawrence Fong ;

L. Claire Tsao ;

George Cole Jr.;

Danelle James ;

Eric Van Cutsem , MD, PhD;

Margaret A. Tempero , MD;

Teresa Macarulla , MD, PhD;

Josep Tabernero , MD, PhD;

Andrew Hendifar ;

Naureen Starling , MBBS, MD;

Dirk-Thomas Waldschmidt ;

07/31/2019

Strategic selection of treatment options in metastatic pancreatic cancer

Teresa Macarulla , MD, PhD;

06/30/2021

HEPANOVA: Final efficacy and safety results from a phase 2 study of Tumor Treating Fields (TTFields, 150 kHz) concomitant with sorafenib in advanced hepatocellular carcinoma

Background Tumor Treating Fields (TTFields) are an anti-mitotic, regional treatment modality, utilizing low intensity alternating electric fields delivered non-invasively to the tumor usi...

Anca-Ligia Grosu ;

Monika Pazgan-Simon ;

Yann Touchefeu ;

Teresa Macarulla , MD, PhD;

Thomas Seufferlein , MD, PhD;

07/01/2021

PROOF 301: A multicenter, open-label, randomized, phase 3 trial of infigratinib vs gemcitabine + cisplatin in patients with advanced cholangiocarcinoma with an FGFR2 gene fusion/rearrangement

Background First-line treatment options are limited for patients with advanced cholangiocarcinoma (CCA). Genetic alterations in the fibroblast growth factor receptor (FG...

Teresa Macarulla , MD, PhD;

Sudipta Roychowdhury , MD;

C. dambkowski ;

Ghassan Abou-Alfa , MD, MBA;

Angela Lamarca , MD, PhD, MSc;

06/27/2022

Debate: Resectable Pancreatic Cancer: Neoadjuvant Chemotherapy in All Patients? - PRO

Teresa Macarulla , MD, PhD;

07/06/2023

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

DCLF

March 17 ⁠–⁠ March 19

NP Institute

March 27 ⁠–⁠ March 30

March 31 ⁠–⁠ April 2

April 21 ⁠–⁠ April 24

April 30 ⁠–⁠ May 4

April 30 ⁠–⁠ May 5

WoundCon

May 1 ⁠–⁠ May 3

May 19 ⁠–⁠ May 21

See Full Calendar